page_title_detailed
general_content

AC-T (doxorubicin and cyclophosphamide followed by paclitaxel), also called AC-T and AC-Taxol, is a chemotherapy combination treatment used to treat breast cancer. It contains these medicines:

Sometimes this regimen is offered with docetaxel (Taxotere) instead of paclitaxel. It would still be called AC-T. Ask your providers to explain why they recommend one taxane over another.

on_this_page
general_content

How AC-T works

Doxorubicin damages the DNA inside the cancer cells. The damage stops the cells from dividing, which causes them to die.

Cyclophosphamide attaches to and damages the DNA in cancer cells when they are in their resting phase (not dividing). After their DNA is damaged, the cells can’t keep dividing, and their growth slows or stops.

Paclitaxel works by damaging the structure or the “skeleton” that supports cancer cells. This stops the cancer cells from growing and dividing. Docetaxol (taxotere) works in a similar way and is sometimes used instead of paclitaxel.

general_content

Who gets AC-T

AC-T is a standard regimen for breast cancers that require treatment with chemotherapy. Women with cancer of a higher grade and younger women often get this combination. It can also be used in people who have had a recurrence depending the medicines you received for early-stage disease.

AC-T can be given after surgery as adjuvant therapy, or before surgery as neoadjuvant therapy. Sometimes the AC portion is given before surgery and the taxane after, based on the cancer that remains in the breast after surgery.

You and your doctor will discuss the best chemotherapy treatment for your situation.

general_content

How AC-T is given

AC-T is usually given in eight treatments, once every 3 weeks. The first four treatments are AC, and the next four are paclitaxel (T). Sometimes the paclitaxel is given weekly at a lower dose instead of every 3 weeks. The whole course of AC-T treatment takes about 5 months.

AC-T is more commonly given on a dose-dense schedule of AC every 2 weeks for a total of four cycles, followed by T every 2 weeks for a total of four cycles.

Both AC and T are given by vein into your hand or arm.

Sometimes docetaxel is used instead of paclitaxel. The AC portion is given once every three weeks followed by docetaxel, which is also given once every three weeks.

general_content

Side effects and things to remember

Different medicines have different side effects. You may not have every side effect related to each medicine of the combination therapy.

Side effects of AC-T may include:

Your doctor will check your blood before you start treatment. If your blood count is low then your treatment may be delayed.

Be sure to tell your doctor about any medicines you are taking, including vitamins, herbal supplements, and over-the counter-medicines, to make sure they will not interfere with your chemotherapy treatment.

Drinking a lot of fluids can help avoid kidney and bladder side effects. Ask your doctor how much and how often you should drink each day. You should also avoid getting too much sun. When you go outside, wear sunscreen and clothes that cover your skin. Contact your doctor right away if you develop a fever or other symptoms of an infection such as a sore throat, cough or diarrhea.

Talk to your doctor, pharmacist or nurse about all your side effects so that they can help you manage them. You can also go to our section on Side Effects for more information.

stay_connected

Stay Connected

Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.

about_this_page_tabbed_module

Reviewed and updated: August 31, 2015

Reviewed by: Laura Spring MD

Tagged:

Was this page helpful?

Living Beyond Breast Cancer is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer. To fulfill its mission of providing trusted information and a community of support to those impacted by the disease, Living Beyond Breast Cancer offers on-demand emotional, practical, and evidence-based content. For over 30 years, the organization has remained committed to creating a culture of acceptance — where sharing the diversity of the lived experience of breast cancer fosters self-advocacy and hope. For more information, learn more about our programs and services.